«Short-term efficacy of a monoclonal antibody fragment (brolucizumab) for treating neovascular age-related macular degeneration», Ukr. j. ophthalmol. , вип. 3, с. 28–32, Лип 2024, doi: 10.31288/oftalmolzh202432832.